Centers of Cancer Nanotechnology Excellence (CCNEs)(U54)
The summary for the Centers of Cancer Nanotechnology Excellence (CCNEs)(U54) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Centers of Cancer Nanotechnology Excellence (CCNEs)(U54): Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI) solicits grant applications to establish a collaborative network of Centers for Cancer Nanotechnology Excellence (CCNEs) within the NCI Alliance for Nanotechnology in Cancer (The Alliance) program (http://nano.cancer.gov). Whereas CCNEs will form the core of the Alliance, they will be accompanied by smaller awards for cancer nanotechnology platform projects (CNPPs) and training programs. This initiative is open to all qualified applicants regardless of whether or not they participated in the previous issuance of the program. CCNEs are designed to link physical scientists, engineers, and technologists working at the nanoscale with cancer biologists and oncologists specializing in the diagnosis, prevention, and treatment of cancer to enable multi-disciplinary team research. CCNE awards will support the development of techniques and tools based on nanotechnology and applicable to: early disease diagnosis using in vitro assays and devices and in vivo imaging techniques; multifunctional therapeutic solutions; and techniques for cancer prevention and control. Multi-disciplinary research teams to be established should collectively have the breadth of expertise that would allow them to: (a) identify innovative research approaches and (b) demonstrate the translational potential of the technological solution in oncology. The overall goal is a rapid advance of nanotechnology discoveries and their transformation into cancer-relevant applications with a potential clinical utility.
|Federal Grant Title:||Centers of Cancer Nanotechnology Excellence (CCNEs)(U54)|
|Federal Agency Name:||National Institutes of Health|
|Grant Categories:||Education Health|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||RFA-CA-09-012|
|Type of Funding:||Cooperative Agreement|
|CFDA Descriptions:||Cancer Cause and Prevention Research|
|Current Application Deadline:||Oct 14, 2009|
|Original Application Deadline:||Oct 14, 2009|
|Posted Date:||May 28, 2009|
|Creation Date:||May 29, 2009|
|Archive Date:||Nov 14, 2009|
|Total Program Funding:|
|Maximum Federal Grant Award:||$3,200,000|
|Minimum Federal Grant Award:|
|Expected Number of Awards:|
|Cost Sharing or Matching:||No|
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Public and State controlled institutions of higher education - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Regional Organizations; U.S. Territory or Possession.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
- Similar Government Grants
- • Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control (R01 Clinic...
- • U.S. and Low- and Middle-Income Country (LMIC) HIV-Associated Malignancy Research Centers ...
- • Continuation of the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancrea...
- • Limited Competition: Continuation of the Consortium for the Study of Chronic Pancreatitis,...
- • Cancer Intervention and Surveillance Modeling Network (CISNET) (U01 Clinical Trial Not All...
- • Pilot Studies in Pancreatic Cancer
- • Cancer Prevention Research Small Grant Program
- • Molecular Targets for Nutrients in Prostate Cancer Prevention
- More Grants from the National Institutes of Health
- • Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
- • A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
- • Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
- • HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
- • National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan...